Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,200.20
+33.40 (2.86%)
At close: Jun 3, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 125.7 billion as of June 3, 2026. Its market cap has decreased by -20.20% in one year.
Market Cap
125.70B
Enterprise Value
121.54B
Revenue
10.55B
Ranking
n/a
PE Ratio
48.18
Stock Price
1,200.20
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 125.70B, an increase of 27.44%. That is a compound annual growth rate of 9.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 122.00B | -13.33% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 341.60B |
| AstraZeneca Pharma India | 217.98B |
| Rubicon Research | 214.60B |
| Granules India | 192.50B |
| Jubilant Pharmova | 155.32B |
| Caplin Point Laboratories | 150.09B |
| Viyash Scientific | 108.22B |
| CORONA Remedies | 104.00B |